STOCK-BASED COMPENSATION (Tables)

12 Months Ended

Dec. 31, 2022

Share-Based Payment Arrangement [Abstract]

Schedule of pre-tax compensation expense and the related income tax benefit for these stock-based incentives

Pre-tax compensation expense included in income from continuing operations for these stock-based incentives was as follows, in millions:

	Year Ended December 31,
	2022		2021		2020
Restricted stock units	$	32	$	28	$	13
Performance restricted stock units	3		10		5
Stock options	7		7		7
Long-term stock awards	6		10		14
Phantom stock awards	1		6		4
Total	$	49	$	61	$	43

Schedule of the Company's long-term stock award activity

Our restricted stock unit activity was as follows, units in thousands:

	Year Ended December 31,
	2022			2021			2020
	Number of Shares	Weighted Average Grant Date Fair Value		Number of Shares	Weighted Average Grant Date Fair Value		Number of Shares	Weighted Average Grant Date Fair Value
Unvested restricted stock units at January 1	934	$	54	435	$	47	—	$	—
Granted	621	59		670	57		446	47
Vested	(351)	53		(142)	47		—	—
Forfeited	(50)	54		(29)	54		(11)	48
Unvested restricted stock units at December 31	1,154	$	57	934	$	54	435	$	47

Our long-term stock award activity was as follows, shares in thousands:

	Year Ended December 31,
	2022			2021			2020
	Number of Shares	Weighted Average Grant Date Fair Value		Number of Shares	Weighted Average Grant Date Fair Value		Number of Shares	Weighted Average Grant Date Fair Value
Unvested stock award shares at January 1	608	$	37	1,125	$	36	1,910	$	34
Vested	(324)	37		(491)	34		(655)	32
Forfeited	(11)	38		(26)	36		(130)	35
Unvested stock award shares at December 31	273	$	38	608	$	37	1,125	$	36

Information related to phantom stock awards was as follows, dollars in millions and shares in thousands:

	At December 31,
	2022		2021
Accrued compensation cost liability	$	5	$	8
Unrecognized compensation cost	$	2	$	3
Equivalent common shares	149		169

Schedule of the Company's stock option activity

Our stock option activity was as follows, shares in thousands:

	Year Ended December 31,
	2022			2021			2020
	Number of Shares	Weighted Average Exercise Price		Number of Shares	Weighted Average Exercise Price		Number of Shares	Weighted Average Exercise Price
Outstanding stock options at January 1	2,692	$	37	2,488	$	33	3,006	$	27
Granted	338	59		332	56		421	48
Exercised	(32)	34		(128)	25		(878)	17
Forfeited	(10)	37		—	11		(61)	40
Outstanding stock options at December 31	2,988	$	39	2,692	$	37	2,488	$	33
Vested and expected to vest stock options at December 31	2,966	$	39	2,617	$	36	2,338	$	33
Exercisable (vested) stock options at December 31	2,051	$	34	1,606	$	31	1,283	$	28

Schedule of weighted average grant date fair value of option shares granted and the assumptions used to estimate those values using a Black-Scholes option pricing model

The weighted average grant date fair value of option shares granted and the assumptions used to estimate those values using a Black-Scholes option pricing model were as follows:

	Year Ended December 31,
	2022			2021			2020
Weighted average grant date fair value	$	14.66		$	13.61		$	10.67
Risk-free interest rate	1.90		%	0.75		%	1.53		%
Dividend yield	1.89		%	1.67		%	1.14		%
Volatility factor	29.00		%	30.00		%	24.00		%
Expected option life	6 years			6 years			6 years

Summary of stock option shares outstanding and exercisable

The following table summarizes information for stock option shares outstanding and exercisable, shares in thousands:

At December 31, 2022
	Option Shares Outstanding				Option Shares Exercisable
	Range of Prices	Number of Shares	Weighted Average Remaining Option Term	Weighted Average Exercise Price	Number of Shares	Weighted Average Exercise Price
$	17 - 21	191	1	$20	191	$20
$	22 - 26	628	3	$24	628	$24
$	27 - 36	786	5	$35	604	$35
$	37 - 60	1,383	7	$51	628	$47
$	17 - 60	2,988	5	$39	2,051	$34